175 related articles for article (PubMed ID: 21326331)
1. Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9.
Van der Perren A; Toelen J; Carlon M; Van den Haute C; Coun F; Heeman B; Reumers V; Vandenberghe LH; Wilson JM; Debyser Z; Baekelandt V
Gene Ther; 2011 May; 18(5):517-27. PubMed ID: 21326331
[TBL] [Abstract][Full Text] [Related]
2. Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats.
Paterna JC; Feldon J; Büeler H
J Virol; 2004 Jul; 78(13):6808-17. PubMed ID: 15194756
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain.
Kornum BR; Stott SR; Mattsson B; Wisman L; Ettrup A; Hermening S; Knudsen GM; Kirik D
Exp Neurol; 2010 Mar; 222(1):70-85. PubMed ID: 20025873
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
Mandel RJ; Snyder RO; Leff SE
Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
[TBL] [Abstract][Full Text] [Related]
5. [Gene transfer efficiencies and cell tropism of recombinant adeno-associated virus in the hippocampus of adult rat].
L i SF; Li ZJ; Li GL; Dou WC; Zhang ZX; Wei JJ; Kong YG; Xu L; Gao J; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):512-6. PubMed ID: 16995303
[TBL] [Abstract][Full Text] [Related]
6. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection.
Hellström M; Ruitenberg MJ; Pollett MA; Ehlert EM; Twisk J; Verhaagen J; Harvey AR
Gene Ther; 2009 Apr; 16(4):521-32. PubMed ID: 19092858
[TBL] [Abstract][Full Text] [Related]
7. [Expression of enhanced green fluorescent protein in rat brain transduced by recombinant adeno-associated viruses type 1 and type 2].
Li SF; Wang RZ; Li GL; Hu GJ; Zhang B; Dou WC; Gu JG; Zhang ZX; Kong YG; Wei JJ; Wei YK; Tian Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):542-6. PubMed ID: 15949335
[TBL] [Abstract][Full Text] [Related]
8. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors.
Blits B; Derks S; Twisk J; Ehlert E; Prins J; Verhaagen J
J Neurosci Methods; 2010 Jan; 185(2):257-63. PubMed ID: 19850079
[TBL] [Abstract][Full Text] [Related]
10. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.
Klein RL; Meyer EM; Peel AL; Zolotukhin S; Meyers C; Muzyczka N; King MA
Exp Neurol; 1998 Apr; 150(2):183-94. PubMed ID: 9527887
[TBL] [Abstract][Full Text] [Related]
11. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
13. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
[TBL] [Abstract][Full Text] [Related]
14. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
[TBL] [Abstract][Full Text] [Related]
17. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR; Sferra TJ; Lo W; Qu G; Chen R; Johnson PR
J Drug Target; 1999 Dec; 7(4):269-83. PubMed ID: 10682906
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
20. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
